Table 1 –
Incidence and cumulative risk of kidney cancer in Europe
| Population | Qualitya | Numbers | Crude rate | ASR (W) | Cumulative risk | 
|---|---|---|---|---|---|
| Czech Republic | A2 | 3313 | 31.4 | 16.7 | 2.01 | 
| Lithuania | A1 | 773 | 23.5 | 13.2 | 1.61 | 
| Slovakia | A1 | 1063 | 19.4 | 12.5 | 1.49 | 
| Estonia | A1 | 284 | 21.2 | 11.7 | 1.39 | 
| Belarus | A2 | 1575 | 16.5 | 11.1 | 1.29 | 
| Slovenia | A1 | 400 | 19.6 | 11.1 | 1.27 | 
| Latvia | A1 | 449 | 20.1 | 10.9 | 1.31 | 
| Germany | B2 | 18 615 | 22.7 | 10.6 | 1.27 | 
| Croatia | A2 | 821 | 18.7 | 10.0 | 1.16 | 
| France (metropolitan) | B2 | 11 023 | 17.4 | 9.7 | 1.14 | 
| Norway | A2 | 798 | 16.1 | 9.3 | 1.08 | 
| Hungary | G1 | 1554 | 15.6 | 9.1 | 1.03 | 
| Russian Federation | D2 | 19 313 | 13.5 | 8.9 | 1.05 | 
| Iceland | A1 | 45 | 13.7 | 8.8 | 1.17 | 
| The Netherlands | A2 | 2679 | 16.0 | 8.8 | 1.04 | 
| Italy | B2 | 11 300 | 18.5 | 8.7 | 1.01 | 
| Belgium | A2 | 1763 | 16.3 | 8.7 | 1.03 | 
| Ireland | A1 | 571 | 12.5 | 8.4 | 0.99 | 
| Luxembourg | D2 | 70 | 13.4 | 8.3 | 1.00 | 
| UK | A1 | 9714 | 15.5 | 8.2 | 0.93 | 
| Poland | C3 | 5244 | 13.7 | 8.1 | 0.95 | 
| Malta | A1 | 57 | 13.6 | 8.0 | 0.91 | 
| Austria | A2 | 1322 | 15.7 | 8.0 | 0.95 | 
| Finland | A1 | 882 | 16.3 | 7.9 | 0.90 | 
| Spain | B2 | 6474 | 13.8 | 7.9 | 0.89 | 
| Ukraine | A2 | 5240 | 11.7 | 7.5 | 0.87 | 
| Serbia | B2 | 1127 | 11.4 | 7.4 | 0.85 | 
| Denmark | A2 | 754 | 13.5 | 7.2 | 0.87 | 
| Bulgaria | A2 | 881 | 11.9 | 6.9 | 0.80 | 
| Montenegro | G6 | 59 | 9.3 | 6.6 | 0.75 | 
| Switzerland | B2 | 948 | 12.3 | 6.5 | 0.74 | 
| Sweden | A2 | 1125 | 11.8 | 6.4 | 0.75 | 
| Albania | G3 | 228 | 7.1 | 5.8 | 0.71 | 
| Romania | E1 | 1940 | 9.1 | 5.7 | 0.66 | 
| Bosnia Herzegovina | D5 | 292 | 7.8 | 5.2 | 0.57 | 
| Portugal | C3 | 1004 | 9.4 | 5.0 | 0.57 | 
| Republic of Moldova | G1 | 230 | 6.5 | 4.6 | 0.55 | 
| Greece | G3 | 1094 | 9.6 | 4.5 | 0.48 | 
| FYR Macedonia | G3 | 104 | 5.0 | 3.6 | 0.41 | 
| Cyprus | A3 | 46 | 4.1 | 3.0 | 0.35 | 
ASR = age-standardised rate.
Data are sorted by ASRs. Numbers are expressed per 100 000 people. Reproduced with permission from the International Agency for Research on Cancer [3].
For Quality legend, please refer to the Supplementary material (Level of availability of incidence and mortality data).